250 related articles for article (PubMed ID: 16735607)
1. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers.
Cools M; Drop SL; Wolffenbuttel KP; Oosterhuis JW; Looijenga LH
Endocr Rev; 2006 Aug; 27(5):468-84. PubMed ID: 16735607
[TBL] [Abstract][Full Text] [Related]
2. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
[TBL] [Abstract][Full Text] [Related]
3. Tumor risk in disorders of sex development (DSD).
Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
[TBL] [Abstract][Full Text] [Related]
4. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH
Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975
[TBL] [Abstract][Full Text] [Related]
5. Advances in molecular markers of germ cell cancer in patients with disorders of sex development.
van der Zwan YG; Cools M; Looijenga LH
Endocr Dev; 2014; 27():172-84. PubMed ID: 25247654
[TBL] [Abstract][Full Text] [Related]
6. Tumor risk in disorders of sex development.
Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH
Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977
[TBL] [Abstract][Full Text] [Related]
7. Gonadal development and tumor formation at the crossroads of male and female sex determination.
Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH
Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949
[TBL] [Abstract][Full Text] [Related]
8. Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors.
Cools M; Honecker F; Stoop H; Veltman JD; de Krijger RR; Steyerberg E; Wolffenbuttel KP; Bokemeyer C; Lau YF; Drop SL; Looijenga LH
Hum Pathol; 2006 Jan; 37(1):101-11. PubMed ID: 16360422
[TBL] [Abstract][Full Text] [Related]
9. Tumor risk and clinical follow-up in patients with disorders of sex development.
Cools M; Looijenga LH
Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509
[TBL] [Abstract][Full Text] [Related]
10. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
Pyle LC; Nathanson KL
Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
[TBL] [Abstract][Full Text] [Related]
11. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
12. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.
Looijenga LHJ; Kao CS; Idrees MT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658757
[TBL] [Abstract][Full Text] [Related]
13. Gonadal malignancy in 13 consecutive collected patients with disorders of sex development (DSD) from Semarang (Indonesia).
Juniarto AZ; Setyawati BA; Miranti IP; Santosa A; Hersmus R; Stoop H; Cools M; Oosterhuis JW; Drop SL; Faradz SM; Looijenga LH
J Clin Pathol; 2013 Mar; 66(3):198-204. PubMed ID: 23268320
[TBL] [Abstract][Full Text] [Related]
14. Gonadal tumours and DSD.
Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development.
Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E
Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164
[TBL] [Abstract][Full Text] [Related]
16. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).
Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH
J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162
[TBL] [Abstract][Full Text] [Related]
17. The biology of germ cell tumors in disorders of sex development.
Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH
Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895
[TBL] [Abstract][Full Text] [Related]
18. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
[TBL] [Abstract][Full Text] [Related]
19. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update.
Ulbright TM
Int J Gynecol Pathol; 2014 Jul; 33(4):365-73. PubMed ID: 24901396
[TBL] [Abstract][Full Text] [Related]
20. Managing the risk of germ cell tumourigenesis in disorders of sex development patients.
Cools M; Looijenga LH; Wolffenbuttel KP; T'Sjoen G
Endocr Dev; 2014; 27():185-96. PubMed ID: 25247655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
